Evidence map›Paper›PMID 36145671›Full record

ArticlePharmaceutics2022

Magnetoresponsive Functionalized Nanocomposite Aggregation Kinetics and Chain Formation at the Targeted Site during Magnetic Targeting.

Sandor I Bernad, Vlad Socoliuc, Daniela Susan-Resiga, Izabell Crăciunescu, Rodica Turcu, Etelka Tombácz, Ladislau Vékás, Maria C Ioncica, Elena S Bernad

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Sandor I BernadRomanian Academy-Timisoara Branch, Centre for Fundamental and Advanced Technical Research, Mihai Viteazul Str. 24, 300223 Timisoara, Romania.ORCID 0000-0002-0617-5376
Vlad SocoliucRomanian Academy-Timisoara Branch, Centre for Fundamental and Advanced Technical Research, Mihai Viteazul Str. 24, 300223 Timisoara, Romania.ORCID 0000-0003-0529-1911
Daniela Susan-ResigaRomanian Academy-Timisoara Branch, Centre for Fundamental and Advanced Technical Research, Mihai Viteazul Str. 24, 300223 Timisoara, Romania.
Izabell CrăciunescuNational Institute for Research and Development of Isotopic and Molecular Technologies (INCDTIM), Donat Str. 67-103, 400293 Cluj-Napoca, Romania.
Rodica TurcuNational Institute for Research and Development of Isotopic and Molecular Technologies (INCDTIM), Donat Str. 67-103, 400293 Cluj-Napoca, Romania.
Etelka TombáczSoós Ernő Water Technology Research and Development Center, University of Pannonia, Zrínyi M. Str. 18, 8800 Nagykanizsa, Hungary.ORCID 0000-0002-2068-0459
Ladislau VékásRomanian Academy-Timisoara Branch, Centre for Fundamental and Advanced Technical Research, Mihai Viteazul Str. 24, 300223 Timisoara, Romania.ORCID 0000-0002-8553-4049
Maria C IoncicaResearch Center for Engineering of Systems with Complex Fluids, Politehnica University Timisoara, Mihai Viteazul Str. 1, 300222 Timisoara, Romania.
Elena S BernadDepartment of Obstetrics and Gynecology, University of Medicine and Pharmacy "Victor Babes" Timisoara, P-ta Eftimie Murgu 2, 300041 Timisoara, Romania.ORCID 0000-0003-1084-2714
National Institute for Research and Development of Isotopic and Molecular Technologies · ROPolytechnic University of Timişoara · RORomanian Academy · ROUniversity of Pannonia · HUVictor Babeș University of Medicine and Pharmacy Timișoara · ROWest University of Timişoara · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug therapy for vascular disease has been promoted to inhibit angiogenesis in atherosclerotic plaques and prevent restenosis following surgical intervention. This paper investigates the arterial depositions and distribution of PEG-functionalized magnetic nanocomposite clusters (PEG_MNCs) following local delivery in a stented artery model in a uniform magnetic field produced by a regionally positioned external permanent magnet; also, the PEG_MNCs aggregation or chain formation in and around the implanted stent. The central concept is to employ one external permanent magnet system, which produces enough magnetic field to magnetize and guide the magnetic nanoclusters in the stented artery region. At room temperature (25 °C), optical microscopy of the suspension model's aggregation process was carried out in the external magnetic field. According to the optical microscopy pictures, the PEG_MNC particles form long linear aggregates due to dipolar magnetic interactions when there is an external magnetic field. During magnetic particle targeting, 20 mL of the model suspensions are injected (at a constant flow rate of 39.6 mL/min for the period of 30 s) by the syringe pump in the mean flow (flow velocity is Um = 0.25 m/s, corresponding to the Reynolds number of Re = 232) into the stented artery model. The PEG_MNC clusters are attracted by the magnetic forces (generated by the permanent external magnet) and captured around the stent struts and the bottom artery wall before and inside the implanted stent. The colloidal interaction among the MNC clusters was investigated by calculating the electrostatic repulsion, van der Waals and magnetic dipole-dipole energies. The current work offers essential details about PEG_MNCs aggregation and chain structure development in the presence of an external magnetic field and the process underlying this structure formation.

Indexed as

functional coatingmagnetoresponsive nanocompositenanomedicineparticle aggregationparticle targetingstent targeting

Identifiers

PMID36145671
PMCPMC9503060
OpenAlexW4296588746

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.